Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin

Keiko Motokawa; Sei Kwang Hahn; Teruo Nakamura; Hajime Miyamoto; Tsuyoshi Shimoboji

doi:10.1002/jbm.a.30759

Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin

Journal of Biomedical Materials Research Part A ◽

10.1002/jbm.a.30759 ◽

2006 ◽

Vol 78A (3) ◽

pp. 459-465 ◽

Cited By ~ 39

Author(s):

Keiko Motokawa ◽

Sei Kwang Hahn ◽

Teruo Nakamura ◽

Hajime Miyamoto ◽

Tsuyoshi Shimoboji

Keyword(s):

Hyaluronic Acid ◽

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

In vivo joint synovial fluid disposition of a novel sustained‐release formulation of diclofenac and hyaluronic acid in horses

Journal of Veterinary Pharmacology and Therapeutics ◽

10.1111/jvp.13033 ◽

2021 ◽

Author(s):

Marie Rhodin ◽

Pia Haubro Andersen ◽

Karin Holm Forsström ◽

Carl Ekstrand

Keyword(s):

Hyaluronic Acid ◽

Synovial Fluid ◽

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition

International Journal of Pharmaceutics ◽

10.1016/j.ijpharm.2006.05.024 ◽

2006 ◽

Vol 322 (1-2) ◽

pp. 44-51 ◽

Cited By ~ 44

Author(s):

Sei Kwang Hahn ◽

Eun Ju Oh ◽

Hajime Miyamoto ◽

Tsuyoshi Shimobouji

Keyword(s):

Hyaluronic Acid ◽

Sustained Release ◽

Michael Addition ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Development of Denticap, a Matrix Based Sustained Release Formulation for Treatment of Toothache, Dental Infection and Other Gum Problem

Current Drug Delivery ◽

10.2174/156720109787846270 ◽

2009 ◽

Vol 6 (2) ◽

pp. 199-207 ◽

Cited By ~ 4

Author(s):

Biswajit Mukherjee ◽

Gopa Roy ◽

Soma Ghosh

Keyword(s):

Sustained Release ◽

Dental Infection ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Plasma Levels and Negative Chronotropic Effect of Metoprolol following Single Doses of a Conventional and Sustained Release Formulation C. P. Quarterman, M. J. Kendall, R. G. Welling vol. 15, 97?103 (1979)

European Journal of Clinical Pharmacology ◽

10.1007/bf00562065 ◽

1979 ◽

Vol 16 (3) ◽

pp. 219-219

Author(s):

D. A. Piercy ◽

C. P. Quarterman ◽

M. J. Kendall ◽

P. G. Welling

Keyword(s):

Sustained Release ◽

Plasma Levels ◽

Chronotropic Effect ◽

Release Formulation ◽

Sustained Release Formulation ◽

Negative Chronotropic Effect

Download Full-text

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite

Chemistry Central Journal ◽

10.1186/1752-153x-7-72 ◽

2013 ◽

Vol 7 (1) ◽

Cited By ~ 28

Author(s):

Bullo Saifullah ◽

Mohd Zobir Hussein ◽

Samer Hasan Hussein-Al-Ali ◽

Palanisamy Arulselvan ◽

Sharida Fakurazi

Keyword(s):

Salicylic Acid ◽

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation ◽

Amino Salicylic Acid ◽

Zinc Layered Hydroxide

Download Full-text

P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(12)60124-5 ◽

2012 ◽

Vol 22 ◽

pp. S48

Author(s):

P. Saenger ◽

V. Khadilkar ◽

K.A. Radjuk ◽

E. Bolshova ◽

R. Khadgawat ◽

...

Keyword(s):

Sustained Release ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration of a sustained release formulation to healthy volunteers

International Journal of Pharmaceutics ◽

10.1016/0378-5173(93)90399-z ◽

1993 ◽

Vol 95 (1-3) ◽

pp. 127-133

Author(s):

C. Efthymiopoulos ◽

D.M.F. Edwards ◽

M. Strolin-Benedetti ◽

F. Ruff ◽

C. Advenier ◽

...

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Healthy Volunteers ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure

European Journal of Clinical Pharmacology ◽

10.1007/bf00542156 ◽

1984 ◽

Vol 27 (3) ◽

pp. 259-263 ◽

Cited By ~ 1

Author(s):

O. Dubourg ◽

P. Gueret ◽

A. Ferrier ◽

J. C. Farcot ◽

M. Terdjman ◽

...

Keyword(s):

Sustained Release ◽

Isosorbide Dinitrate ◽

Left Ventricular ◽

Left Ventricular Failure ◽

Ventricular Failure ◽

Release Formulation ◽

Sustained Release Formulation ◽

Haemodynamic Study

Download Full-text

▾ Piretanide for hypertension

Drug and Therapeutics Bulletin ◽

10.1136/dtb.23.11.43 ◽

1985 ◽

Vol 23 (11) ◽

pp. 43-44

Keyword(s):

Glucose Tolerance ◽

Sustained Release ◽

Loop Diuretic ◽

Plasma Potassium ◽

Release Formulation ◽

Sustained Release Formulation ◽

Treatment Of Hypertension

Piretanide is a loop diuretic recently marketed in a sustained-release formulation (Arelix - Hoechst) solely for the treatment of hypertension (rather than as a general diuretic). The manufacturer claims that piretanide has several advantages over the thiazides, including little or no effect on plasma potassium and magnesium, and no impairment of glucose tolerance.

Download Full-text

Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron

Journal of Experimental Pharmacology ◽

10.2147/jep.s68880 ◽

2014 ◽

pp. 15 ◽

Cited By ~ 16

Author(s):

Thomas Ottoboni ◽

Mark Gelder ◽

Erin O’Boyle

Keyword(s):

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text